Analyst Price Target is $2.27
▲ +362.49% Upside Potential
This price target is based on 0 analysts offering 12 month price targets for Ontrak in the last 3 months. The average price target is $2.27, with a high forecast of $3.00 and a low forecast of $1.30. The average price target represents a 362.49% upside from the last price of $0.49.
Current Consensus is
The current consensus among 0 investment analysts is to n/a stock in Ontrak. This rating has held steady since August 2022, when it changed from a Hold consensus rating.
Ontrak, Inc. operates as an artificial intelligence powered, telehealth-enabled, and virtualized healthcare company that provides in-person services to health plans and other third-party payors in the United States. Its technology-enabled platform predicts people whose chronic disease will improve with behavior change, recommends effective care pathways that people are willing to follow, and engages and guides them to and through the care they need. The company's technology-enabled OnTrak program provides healthcare solutions to members with behavioral conditions that cause or exacerbate chronic medical conditions, such as diabetes, hypertension, coronary artery disease, chronic obstructive pulmonary disease, and congestive heart failure. The OnTrak integrates evidence-based psychosocial and medical interventions delivered in-person or via telehealth along with care coaching and in-market community care coordinators, who address the social and environmental determinants of health. The company was formerly known as Catasys, Inc. and changed its name to Ontrak, Inc. in July 2020. The company was incorporated in 2003 and is headquartered in Henderson, Nevada.